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R. Pathak, I.H. Mallick, N. Garg and G. Hamilton*University Department of Surgery, Royal Free Hospital, Hampstead, London NW3 2QG, UKHaemangiopericytomas is a rare vascular tumour. The trunk and lower extremities are involved in most cases. Fifteen to
twenty percent of haemangiopericytomas arise in the head and neck.
We describe a case of a benign metachronous haemangiopericytoma in a 33-year-old man. The lesions were dealt by prompt
surgical excision. This case highlights the need of close long-term follow-up of such patients with haemangiopericytoma even
when benign.Keywords: Haemangiopericytoma; Metachronous; Magnetic resonance imaging; Immunohistochemistry; Surgical excision.Introduction
Haemangiopericytoma is an uncommon mesenchy-
mal tumour which comprises of 1% of all blood vessel-
related neoplasms and approximately 3% of all soft
tissue sarcomas.1 Being uncommon, haemangioper-
icytomas may be difficult to diagnose. About 15–25%
of haemangiopericytomas arise in the head and neck.1
In 1942, Stout and Murray coined the term ‘haeman-
giopericytoma’ for a unique vascular tumour which
was characterised by branching capillaries sur-
rounded by a reticulin network.2 It presents as a
painless mass, affecting males and females equally.
The aetiology is unknown, although the presence of
haemangiopericytoma has been linked to trauma and
hormonal imbalance. The true nature of this neoplasm
is uncertain and its clinical behaviour difficult to
predict. Accurate diagnosis of haemangiopericytoma
is made on the basis of conventional histological along
with the use of immunohistochemical staining tech-
niques with factor VIII-R-Ag, factor XIII and histo-
compatibility antigen HLA-DR.3 The treatment ofing author. Prof G. Hamilton, MS, FRCS, Professor of
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wide surgical excision.1Case Presentation
A 33-year-old Caucasian male presented with a 1-year
history of a painless nodular swelling on the right side
of the neck which was associated with tingling on the
right side of the face. Clinical examination revealed a
tender 3!3.2 cm2 mass in the posterior triangle of the
neck covered by freely movable normal skin. There
had been no increase in the size of the swelling. There
was no evidence of any enlarged lymph nodes.
Technetium bone scan showed increased uptake in
the lateral process of C2. The lesion was excised and
macroscopic appearance consisted of a pseudoencap-
sulated mass measuring 3!3.5 cm2 in diameter. A
portion of the lesion was solid but much of it was
cystic with haemorrhagic necrosis. Histology demon-
strated a cellular tumour with an intricate vascular
network surrounded by polygonal cells in a typical
staghorn a pattern and the excision seemed complete.
Immunohistochemical staining with factor XIIIa
demonstrated staining of the vascular spaces and the
pericytic membranes (Fig. 1). The histological and
immunohistological profiles were consistent with a
benign haemangiopericytoma, with infrequentEJVES Extra 10, 24–26 (2005)
doi:10.1016/j.ejvsextra.2005.04.012, available online at http://www.sciencedirect.com onD license. 
Fig. 1. Immunohistochemical staining with factor XIII shows
intense staining of the vascular spaces and the pericytic
membranes.
Vascular Neck Lumps 25mitoses. Four years from the initial presentation, he
presented with a firm mass in the left side of the neck.
Magnetic resonance (MR) scan demonstrated a well-
circumscribed, lobulated lesion on two-dimensional
images. Furthermore, it revealed a non-uniform high
signal intensity with increased vascularity on T2-
weighted images without infiltration of the surround-
ing tissue (Fig. 2). The lesion was excised and the
histological evaluation proved to be haemangioper-
icytoma. In the following year, he was seen in the clinic
with a firm 3!4 cm2 lump in the right thigh. There
was no evidence of distal neurovascular deficit. The
lesion was excised and the histology proved to beFig. 2. Magnetic resonance (MR) scan demonstrates a well-
circumscribed, lobulated, lesion with non-uniform high
signal intensity with increased vascularity on T2-weighted
images without infiltration of the surrounding tissue.haemangiopericytoma again without any overt fea-
tures of malignancy. The patient has remained well
with no further lumps in the subsequent 6 months
follow-up.
Haemangiopericytoma is an uncommon vascular
tumour that may pose difficulty in diagnosis. Like the
glomus tumour, haemangiopericytoma arises from
capillary pericytes; for this reasons it may arise in any
part of the body where capillaries are present.
Pericytes are slender, elongated cells located in the
walls of capillaries and venules.4 They are external to
the endothelial cells and are separated by a basement
membrane. Whereas, haemangiopericytomas com-
monly arises in the retroperitoneum and lower
extremities, about 15–25% of them arise in the head
and neck region.1 Haemangiopericytoma has no race
predilection and it has been found in patients of all
ages. It presents as a slow-growing, painless mass that
is often nodular andwell circumscribed. The overlying
skin or mucosa is usually normal in appearance. The
diagnosis of this tumour can be problematic. The
differential diagnosis includes lymphomas, neurofi-
bromas, fibrosarcomas and solitary fibrous tumours.
Imaging, biopsy and immunohistochemical staining
are essential for establishing the diagnosis.
Haemangiopericytomas have higher potential of
relapse, local invasiveness, and the possibility of
producing distant metastases. Magnetic resonance
angiography is a better diagnostic method than a
computed tomographic scans for this vascular tumour,
which usually demonstrates hypervascularity. Micro-
scopically the tumour is composed of a large number
of capillaries and small vessels, dense spindle-shaped
tumour cells, and reticular fibres. Imunohistochemi-
cally, haemangiopericytomas are known to show a
positive response to antibodies against vimentin and
type IV collagen, factor XIII and a negative response to
VIII-related antigen, S-100 protein, neuronspecific
enolase carcinoembryonic antigen, desmins, laminin,
and cytokeratins.3
Although distinction between benign and malig-
nant haemangiopericytoma cannot be made in all
cases, careful evaluation of certain morphologic
criteria is helpful in predicting the clinical course.
Prominent mitoses, necrosis, haemorrhage, and
increased cellularity often associated with thrombosis
are features usually observed in tumours that later
recur or metastasise.5
Because of the rarity and unpredictable biologic
behaviour of these neoplasms, there is controversy
about the best way to manage them. It is generally
accepted that the treatment of choice is radical surgical
excision when the tumour is localized and technically
resectable. Radiotherapy is recommended in cases ofEJVES Extra Vol 10, July 2005
R. Pathak et al.26incomplete tumour removal or of unresectable and
recurrent lesions or for palliation. The combination of
radical surgery, postoperative radiation therapy,
and close follow-up represents the most ideal
approach for locally aggressive, non-metastatic hae-
mangiopericytoma. The wide en bloc surgical resection
may be facilitated if the afferent vessels are preopera-
tively embolised to decrease tumour bleeding during
surgery. Because of the high incidence of local
recurrence, long-term follow-up is essential. In the
present patient, the resected surgical margins were
free of tumour and, therefore, no adjuvant radio-
therapy was necessary in all the three sites.
This case report emphasises that haemangiopericy-
toma may be metachronous. In this case, there were no
features of malignancy and excision margins were
uninvolved. Despite this the patient had more lesions
later on. Therefore, we feel that close long-termEJVES Extra Vol 10, July 2005follow-up is essential not only for malignant haeman-
giopericytoma, but also for patients with benign
haemangiopericytomas with uninvolved excision
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